Comprehensive review articles written by international experts are important to provide readers from diverse backgrounds with an expanding knowledge base.
This is a preview of subscription content, log in via an institution to check access.
References
Smolen, J. S. et al. Rheumatoid arthritis. Nat. Rev. Dis. Primers 4, 18001 (2018).
Smolen, J. S. et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update. Ann. Rheum. Dis. https://doi.org/10.1136/annrheumdis-2019-216655 (2020).
Lund Hetland, M. et al. A multicenter randomized study in early rheumatoid arthritis to compare active conventional therapy versus three biological treatments: 24 week efficacy and safety results of the NORD-STAR Trial [abstract L09]. Arthritis Rheumatol. 71 (Suppl. 10), 5237–5240 (2019).
Croft, A. P. et al. Distinct fibroblast subsets drive inflammation and damage in arthritis. Nature 570, 246–251 (2019).
Aletaha, D. & Smolen, J. S. Remission in rheumatoid arthritis: missing objectives by using inadequate DAS28 targets. Nat. Rev. Rheumatol. 15, 633–634 (2019).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
J.S. receives research grants from Abbvie, AstraZeneca, Lilly, Merck Sharpe & Dohme, Pfizer and Roche; and honoraria for expert advice for or symposia speaking engagements with AbbVie, Amgen, AstraZeneca, Astro, Bristol-Myers Squibb, Celgene, Celltrion, Chugai, Gilead, ILTOO Pharma, Janssen, Lilly, Merck Sharp & Dohme, Novartis-Sandoz, Pfizer, Roche, Samsung, Sanofi and UCB.
Rights and permissions
About this article
Cite this article
Smolen, J.S. Rheumatoid arthritis Primer — behind the scenes. Nat Rev Dis Primers 6, 32 (2020). https://doi.org/10.1038/s41572-020-0168-y
Published:
DOI: https://doi.org/10.1038/s41572-020-0168-y
- Springer Nature Limited
This article is cited by
-
The effects of intermittent fasting diet on quality of life, clinical symptoms, inflammation, and oxidative stress in overweight and obese postmenopausal women with rheumatoid arthritis: study protocol of a randomized controlled trial
Trials (2024)
-
Clinical safety and feasibility of a novel implantable neuroimmune modulation device for the treatment of rheumatoid arthritis: initial results from the randomized, double-blind, sham-controlled RESET-RA study
Bioelectronic Medicine (2024)
-
Effect of curcumin on the expression of NOD2 receptor and pro-inflammatory cytokines in fibroblast-like synoviocytes (FLSs) of rheumatoid arthritis (RA) patients
Advances in Rheumatology (2023)
-
Exosome inspired photo-triggered gelation hydrogel composite on modulating immune pathogenesis for treating rheumatoid arthritis
Journal of Nanobiotechnology (2023)
-
Plasma IL-36α and IL-36γ as Potential Biomarkers in Interstitial Lung Disease Associated with Rheumatoid Arthritis: a Pilot Study in the Chinese Population
Inflammation (2023)